Resistance to fusidic acid.

Area of Science:

• Microbiology
• Molecular Biology
• Pharmacology

Background:

• Fusidic acid is a key antibiotic for staphylococcal infections.
• Understanding resistance mechanisms is crucial for effective treatment strategies.
• Staphylococcal resistance to fusidic acid can arise through various pathways.

Purpose of the Study:

• To review the mechanisms of fusidic acid resistance in staphylococci.
• To analyze the prevalence and trends of fusidic acid resistance.
• To evaluate the clinical implications of fusidic acid resistance.

Main Methods:

• Literature review of studies on fusidic acid resistance in staphylococci.
• Analysis of resistance mechanisms including elongation factor G alterations, altered drug permeability, and efflux pumps.
• Examination of resistance rates in various clinical settings and patient populations.

Main Results:

• Common resistance mechanisms involve alterations in elongation factor G and plasmid-borne changes in drug permeability.
• Most studies report low rates of fusidic acid resistance, but higher rates are observed in hospital settings with high cross-infection.
• Methicillin-resistant Staphylococcus aureus strains show slightly higher resistance rates.
• While in vitro and in vivo selection of resistant strains occurs, it is not frequent in clinical practice.

Conclusions:

• Fusidic acid resistance is multifactorial, with elongation factor G alterations being the most understood mechanism.
• Combination therapy with fusidic acid and other agents is recommended to prevent resistance emergence.
• Continued monitoring of resistance patterns is essential for maintaining the efficacy of fusidic acid.